Skip to main content

ClearPoint Neuro, Inc.

CLPT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001285550

No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding ClearPoint Neuro, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CLPT: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders60163+4
Shares5.81M201.6K5.95M+339.2K (+6.1%)
Value$42.0M$1.46M$29.8M−$10.8M (−26.6%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held ClearPoint Neuro, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CLPT in Q3 2023
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC66,992$335.6K0.01%
Goldman Sachs Group Inc47,282$236.9K0.00%
Bank of Montreal28,196$165.2K0.00%
Deutsche Bank AG25,913$129.8K0.00%
SG Americas Securities, LLC16,529$83.0K0.00%
Allspring Global Investments Holdings, LLC4,465$22.4K0.00%
Nisa Investment Advisors, LLC1,605$8.04K0.00%
Group One Trading, L.P.1,062$5.32K0.00%
Jamison Private Wealth Management, Inc.300$1.50K0.00%
NBC Securities, Inc.250$1.00K0.00%
CWM, LLC213$1.00K0.00%
EverSource Wealth Advisors, LLC195$9770.00%

Sold out (8)

Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CLPT in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Millennium Management LLC35,461$256.7K
Marshall Wace, LLP26,372$190.9K
D. E. Shaw & Co., Inc.25,973$188.0K
Susquehanna International Group, LLP23,425$169.6K
Westwood Management Corp14,000$101.0K
Verition Fund Management LLC11,302$81.8K
Simplex Trading, LLC1,600$11.0K
Fairfield, Bush & Co.134$970

Not filed for Q3 2023 yet (1)

Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLPT in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Sentinus, LLC201,590$1.46M